Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410136 · ClinicalTrials.gov registry record · NA
Chondrofix Osteochondral Allograft Prospective Study
A NA study, sponsored by Zimmer Orthobiologics.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01410136: Clinical Trial NA study, sponsored by Zimmer Orthobiologics.
NCT01410136 is a NA study that was terminated before completion, run by Zimmer Orthobiologics. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01410136, a NA study, was terminated before completion, sponsored by Zimmer Orthobiologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is that Chondrofix Allograft will provide pain relief and functional improvement as demonstrated by a comparative analysis of baseline clinical evaluations at 24 months of follow-up.
Primary Outcome
The overall mean change from baseline to 24 months in the KOOS Pain and KOOS Function in Daily Living (ADL) subscale scores.
Interventions
- PROCEDURE Chondrofix Osteochondral Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
Why NCT01410136 stopped before completion
NCT01410136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Chondrofix Osteochondral Allograft is the first listed.
NCT01410136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01410136 about?
NCT01410136 is a clinical study titled "Chondrofix Osteochondral Allograft Prospective Study". The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is tha...
What is the current status of trial NCT01410136?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2011-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01410136?
The interventions under investigation include: Chondrofix Osteochondral Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT01410136?
This trial is sponsored by Zimmer Orthobiologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01410136's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia